Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis

This publication has 39 references indexed in Scilit:

• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
  Pharmacological Reviews, 2002
• Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2002
• Cannabinoid CB₁‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
  British Journal of Pharmacology, 2001
• Possible Involvement of 5-HT4 Receptors, in Addition to 5-HT3 Receptors, in the Emesis Induced by High-Dose Cisplatin in Suncus murinus
  The Japanese Journal of Pharmacology, 2001
• Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
  Biochemical and Biophysical Research Communications, 1999
• Serotonin 5-HT 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
• Physiology of Chemotherapy-Induced Emesis and Antiemetic Therapy
  Drugs, 1997
• Antiemetic Effects of Serotonergic 5-HT1A-Receptor Agonists in Suncus Murinus
  The Japanese Journal of Pharmacology, 1994
• Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
• Vagal Afferent Fibers and Peripheral 5-HT3 Receptors Mediate Cisplatin-Induced Emesis in Dogs
  The Japanese Journal of Pharmacology, 1992